Koichi Akashi mostly deals with Immunology, Haematopoiesis, Myeloid, Progenitor cell and Stem cell. His Immunology research includes themes of Phenotype, Megakaryocyte and Progenitor. His Haematopoiesis research is multidisciplinary, incorporating elements of CD34, Cancer research, Myeloid leukemia and Transcription factor.
His research on Myeloid also deals with topics like
Koichi Akashi spends much of his time researching Immunology, Internal medicine, Haematopoiesis, Stem cell and Cancer research. The various areas that Koichi Akashi examines in his Immunology study include Transplantation, Graft-versus-host disease and Cytotoxic T cell. His Haematopoiesis research is multidisciplinary, incorporating perspectives in Progenitor cell, Myeloid, CD34, Molecular biology and Bone marrow.
His Progenitor cell study introduces a deeper knowledge of Cell biology. Koichi Akashi works in the field of Stem cell, focusing on Hematopoietic stem cell in particular. His Cancer research study combines topics from a wide range of disciplines, such as Cancer stem cell, Cancer and Leukemia.
Koichi Akashi mainly focuses on Internal medicine, Cancer research, Oncology, Gastroenterology and Immunology. His study looks at the intersection of Internal medicine and topics like Cardiology with Cardiotoxicity. His studies deal with areas such as Cancer stem cell, Cancer, Stem cell and Leukemia as well as Cancer research.
His Stem cell study focuses on Haematopoiesis in particular. His research links Progenitor cell with Haematopoiesis. His study in Gastroenterology is interdisciplinary in nature, drawing from both Prospective cohort study, Adverse effect and Tacrolimus.
Koichi Akashi mainly investigates Internal medicine, Cancer research, Gastroenterology, Stem cell and Immunology. In his research, Myelogenous, Leukemia, Discontinuation, Nilotinib and Sokal Score is intimately related to Oncology, which falls under the overarching field of Internal medicine. His research in Cancer research intersects with topics in Cancer, Colorectal cancer and T cell, CD8, Immune system.
His research in Stem cell is mostly concerned with Haematopoiesis. His Haematopoiesis research integrates issues from Aplastic anemia, Bone marrow, Cytotoxic T cell and Progenitor cell. All of his Immunology and Serum samples and Myeloid investigations are sub-components of the entire Immunology study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
A clonogenic common myeloid progenitor that gives rise to all myeloid lineages
Koichi Akashi;Koichi Akashi;David Traver;Toshihiro Miyamoto;Irving L. Weissman.
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Motonari Kondo;Irving L. Weissman;Koichi Akashi.
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
Fumihiko Ishikawa;Masaki Yasukawa;Bonnie Lyons;Shuro Yoshida.
The aging of hematopoietic stem cells
Sean J. Morrison;Sean J. Morrison;Antoni M. Wandycz;Koichi Akashi;Amiela Globerson.
Nature Medicine (1996)
Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.
Fumihiko Ishikawa;Shuro Yoshida;Yoriko Saito;Atsushi Hijikata.
Nature Biotechnology (2007)
Bcl-2 Rescues T Lymphopoiesis in Interleukin-7 Receptor–Deficient Mice
Koichi Akashi;Motonari Kondo;Ursula von Freeden-Jeffry;Richard Murray.
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
Brian J.P. Huntly;Hirokazu Shigematsu;Kenji Deguchi;Benjamin H. Lee.
Cancer Cell (2004)
Mouse Development and Cell Proliferation in the Absence of D-Cyclins
Katarzyna Kozar;Maria A. Ciemerych;Vivienne I. Rebel;Hirokazu Shigematsu.
Prospective isolation of human clonogenic common myeloid progenitors
Markus G. Manz;Toshihiro Miyamoto;Koichi Akashi;Irving L. Weissman.
Proceedings of the National Academy of Sciences of the United States of America (2002)
Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells.
Joseph T. Opferman;Joseph T. Opferman;Hiromi Iwasaki;Christy C. Ong;Christy C. Ong;Heikyung Suh;Heikyung Suh.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: